U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206537) titled 'The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome' on Sept. 26.
Brief Summary: Long-term glucocorticoids therapy is associated with various complications, including decreased bone strength (Glucocorticoid-induced osteoporosis) and an increased risk of fracture.
Vitamin K2 has been recently deemed appreciable as a topic of research as it plays a pivotal role in maintenance of the bone strength, and it has been proved to have a positive impact on the bone metabolism.
This study examines the impact of oral vitamin K2 supplementation on bone metabolism in pediatric patients with n...